Show simple item record

dc.contributor.authorHorton, Gemma
dc.contributor.authorMaumi, Gurbinder
dc.contributor.authorJames, Katie
dc.contributor.authorJainer, Ashok Kumar
dc.contributor.authorSomashekar, Bettahalasoor
dc.date.accessioned2024-05-28T08:36:18Z
dc.date.available2024-05-28T08:36:18Z
dc.date.issued2020-08
dc.identifier.citationInternational Medical Journal Vol. 27, No. 4, pp. 433 - 437, August 2020en_US
dc.identifier.urihttp://hdl.handle.net/20.500.14200/4652
dc.description.abstractIntroduction: We aimed to examine the changing trends in development of antipsychotics in the past half century. Materials and Methods: A comprehensive literature search was completed, using MEDLINE, EMBASE and the Cochrane library. Findings/conclusion: During the past half century, numerous first-, second- and third-generation antipsychotics have been developed, in response to the identification of side effects such as extra pyramidal and metabolic side effects. Development of new antipsychotics however, is not only due to a wish to avoid troublesome side effects, but due to a desire to target specific fea tures of schizophreniaen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectMental healthen_US
dc.subjectPharmacologyen_US
dc.titleDevelopment of new antipsychotics: changing trendsen_US
dc.typeArticleen_US
dc.source.journaltitleInternational Medical Journalen_US
rioxxterms.versionAOen_US
oa.grant.openaccessyesen_US


This item appears in the following Collection(s)

Show simple item record